Dermatology and Aesthetics has always been an important Therapy Area (TA) for Alkem. We cater to this segment through integration, innovation, and enhancement of our diverse Dermatology and Cosmetology portfolio. It includes moisturizers and products for acne, vitiligo, skin infections, melasma, dermatitis, alopecia, and skin revitalization. Our incredible range of formulations makes us stand out in this TA, for all the right reasons.
Keeping up with our principle of not stopping and confining ourselves, we impart updated medical education through national symposiums, international and domestic conference participation, round table discussions, and live webcasts for online discussions for the medical fraternity.
Highlights of Alkem’s Dermatology portfolio:
Melbild (our brand of Decapeptide) was the biggest launch of the segment in 2015.
Alkem acquired Clindac-A – a leading brand in the Clindamycin topical market from Galderma.
Renocia (our range for alopecia available as serum, shampoo, and conditioner) is an in-licensed product from South Korea – a known leader in this sector.
We launched Olesoft-an emollient catering to various needs of moisturization.
Olesoft Max is emerging as one of the top choices of moisturizer for atopic dermatitis.
Kojiglo Gold is a unique combination with the promise to lighten up acne-induced hyper-pigmentation.
Some of key brands are:
- LILITUF
- PRUCROS
- RENOCIA
- CLINDAC A
- CLINDAC AP
- SUNHEAL
- HYMOS